Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-14 · accession 0001062993-25-005645 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-17 | 2025-03-14 | ADPT | PISKEL KYLE | CFO | M - OptEx | $6.32 | +2,500 | 271.5K | +0.9% | +$15.8K |
| D | 2025-03-17 | 2025-03-14 | ADPT | PISKEL KYLE | CFO | M - OptEx | $0.00 | -2,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-14 | M | A | 2,500 | $6.32 | 271,510 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-03-14 | M | D | 2,500 | $0.00 | 0 | D | $6.32 · — to 2026-11-08 | 2,500 Common Stock | (F1) The option was fully vested and exercisable. |